- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02681406
Smartphone Based Continuing Care for Alcohol
Impact of Enhancements to Smartphone Based Continuing Care for Alcohol Dependence
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Continuing care is believed to be important in the effective management of patients with alcohol use disorders. New smartphone technology provides a novel way to provide personalized continuing care support. Dr. Gustafson and colleagues at the University of Wisconsin have developed an addiction version of CHESS (ACHESS), an automated smart phone system that provides a range of functions designed to directly support patients. In a recently completed NIAAA-funded continuing care study, ACHESS produced better drinking outcomes with alcoholics than treatment as usual.
The Principal Investigator of the current study, Dr. Jim McKay, and his colleagues at the Center of Continuum of Care in the Addictions have also developed a telephone-based approach to continuing care, Telephone Monitoring and Counseling (TMC), which has demonstrated efficacy in two randomized trials with alcohol-dependent patients. The TMC intervention is delivered through telephone contacts between patients and counselors, and makes use of information obtained in a brief assessment at the beginning of each call to determine the content of the session and to trigger adaptive changes in level of care over time.
Although both ACHESS and TMC use telephone technology, they have complementary strengths. ACHESS provides a range of automated 24/7 recovery support services, but does not include contact with a counselor. TMC, on the other hand, provides regular and sustained contact with the same counselor, but does not provide support between calls. The future of continuing care for alcohol use disorders is likely to involve both automated mobile technology and counselor contact, but little is known about how best to integrate these services.
To address this question, the study will feature a 2 x 2 design [ACHESS for 12 months (yes/no) x TMC for 12 months (yes/no)]. With this design, we will determine whether adding TMC to ACHESS produces superior outcomes to those obtained with TMC or ACHESS alone. This design will also enable replication of prior findings, and will provide the first direct comparison of TMC only vs. ACHESS only. In addition, economic analyses will be completed to determine the cost and cost-effectiveness of each intervention and their combination. The participants will be randomly assigned into one of the four conditions and followed for 18 months. The follow-ups will be at 3, 6, 9, 12, and 18 months post-baseline.
The subjects will be 280 patients diagnosed with alcohol abuse who are in a substance abuse treatment center in the Philadelphia area.
The risks of the research are conceived to be minimal (e.g., possible embarrassment) and consist of those incurred in providing self-report data on alcohol and drug-related history and social and psychiatric problems. There are minimal medical risks associated with research participation. There will be some risk of loss of confidentiality since the name, addresses and phone numbers of three contact people will be recorded by the staff for subject tracking purposes. However, all identifiable information will remain in a locked filling cabinet only accessible by the principle investigator and study staff. No identifying information will be programmed into the phone by the counselor. Although the participant is able to program numbers into the smartphone once they receive one, the counselor will review several measures for protecting the subjects' privacy, including password and pattern locks. All subjects will receive at a minimum treatment as usual in the programs from which they will be recruited.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- have a DSM-V diagnosis of current, moderate to severe alcohol use disorder
- have completed 3 weeks of IOP
- be 18-75 years of age
- be able to provide the name and verified telephone number of at least two contacts to help reach participants for follow up appointments
- functionally literate and have sufficient ability to read a smart phone
- be willing to be randomized as part of the clinical trial
Exclusion Criteria:
- have a current psychotic disorder or dementia severe enough to prevent participation in treatment
- have an acute medical problem requiring immediate inpatient treatment
- are participating in other forms of treatment for substance abuse, besides IOP
- are unable to read/comprehend for informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Treatment as Usual
Participants randomized to this condition will continue their schedules and treatments as they had been and just come in to see research staff for research visits.
|
|
|
Experimental: Telephone Monitoring and Counseling
TMC - participants receive brief (20 minute) telephone counseling once weekly, then biweekly, etc for 12 months.
|
Brief telephone monitoring and counseling
|
|
Experimental: ACHESS
Participants are signed up for an addiction based smart phone application that connects them in an anonymous fashion to a social network of other people in the study who are also struggling with alcohol addiction and sober living.
|
Smartphone based additions focused application, encouraging social support
|
|
Experimental: TMC + ACHESS
Participants in this arm receive both interventions - the telephone counseling plus the ACHESS phone application.
|
Brief telephone monitoring and counseling
Smartphone based additions focused application, encouraging social support
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time Line Follow Back, Percent Heavy Alcohol Use
Time Frame: 18 month: months 13 - 18 post baseline
|
The primary outcome measure will be percent days of heavy alcohol use (i.e., > 5 drinks/day for men, > 4 drinks/day for women) within each follow-up period.
Studies have consistently supported the reliability and validity of the TLFB with alcohol dependent individuals.
Frequency of heavy alcohol use was selected because alcohol-related problems are correlated with the frequency of heavy drinking days.
This outcome is also sensitive to reductions in problematic or high risk use, which are particularly important in a disease management model.
|
18 month: months 13 - 18 post baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: James R. McKay, PhD, University of Pennsylvania
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 819881
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Abuse
-
BrainswayRecruitingAlcohol Dependence | Alcoholism | Alcohol Use Disorder | Alcohol Abuse | Alcohol Addiction | Alcohol Abuse/DependenceUnited States, Israel
-
The Morton Center, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA)UnknownAlcohol Dependence | Cannabis Dependence | Alcohol Abuse | Cannabis Abuse | Other Substance AbuseUnited States
-
Michael E. DeBakey VA Medical CenterUnknownAlcohol Dependence | Alcohol Abuse | Substance Abuse ProblemUnited States
-
Polaris Health DirectionsUniversity of Massachusetts, WorcesterCompletedAlcohol Abuse, Alcohol DependenceUnited States
-
Australian National UniversityUniversity of Peradeniya; Department of Foregin Affairs and Trade, AustraliaCompletedIntimate Partner Violence | Domestic Abuse | Drug and Alcohol AbuseAustralia
-
University of Southern CaliforniaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingAlcohol Consumption | Alcohol Abuse/DependenceUnited States
-
Kent State UniversityCompletedAlcohol Use Disorder | Alcohol Abuse | Alcohol Abuse, EpisodicUnited States
-
National Institute on Drug Abuse (NIDA)CompletedDrug/Substance Abuse/Addiction | Alcohol Abuse/AddictionUnited States
-
Queen Mary University of LondonBarts & The London NHS Trust; University of HertfordshireCompletedAlcohol Use Disorder | Alcohol Abuse or DependenceUnited Kingdom
-
Gulhane School of MedicineRecruitingAlcohol Abuse/DependenceTurkey
Clinical Trials on TMC
-
Modum BadCompletedComplex Post-Traumatic Stress DisorderNorway
-
West German Center of Diabetes and HealthCompleted
-
Fundació d'investigació Sanitària de les Illes...Hospital Son EspasesRecruitingFirst CarpoMetacarpal Osteoartrithis | Basal Thumb OsteoartrithisSpain
-
Gangnam Severance HospitalCompletedStomach Cancer | Colorectal Cancer | Pancreatobiliary CancerKorea, Republic of
-
Ajay Wasan, MD, MscNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
Cancer Institute and Hospital, Chinese Academy...RecruitingEsophageal Cancer | Chemotherapy | Immunotherapy | Chemoradiotherapy | NimotuzumabChina
-
Massachusetts General HospitalUniversity of Miami; Fenway Community HealthCompletedStress Disorders, Post-Traumatic | Sexual Risk Behavior | Childhood Sexual AbuseUnited States
-
Johns Hopkins Bloomberg School of Public HealthAnnamalai UniversityCompletedPneumonia | Diarrhea | Growth | Child Development | Febrile IllnessIndia
-
International Partnership for Microbicides, Inc.CompletedHIV PreventionSouth Africa, Uganda
-
Ascletis Pharmaceuticals Co., Ltd.Beijing YouAn HospitalCompleted